Showing 101-110 of 6967 results for "".
The Art of Medicine in the Age of Technology
https://practicaldermatology.com/topics/practice-management/the-art-of-medicine-in-the-age-of-technology/21065/Although electronic technology offers potential for a more efficient delivery of healthcare, the patient experience may suffer as a result.Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of Imlygic6 Tips to Stay Updated with Social Media Trends
https://practicaldermatology.com/topics/practice-management/6-tips-to-stay-updated-with-social-media-trends/21204/Staying on top of social media trends allows physicians to maintain a marketing edge.The Most Important Element of Your Financial Plan, Part II
https://practicaldermatology.com/topics/practice-management/the-most-important-element-of-your-financial-plan-part-ii/21313/Why flexibility is crucial to meeting long-term goals.Build Leadership Skills in Staff Members
https://practicaldermatology.com/topics/practice-management/build-leadership-skills-in-staff-members/19110/Todd E. Schlesinger, MD discusses strategies for cultivating leadership among staff and highlights the importance of positioning staff to succeed.Regression in Primary Melanomas: Histologic Factors and Prognosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/regression-in-primary-melanomas-histologic-factors-and-prognosis/21367/Regression was once thought to be a negative prognostic factor in primary melanomas, but new findings suggest otherwise.DermwireTV — Revance’s Neurotoxin Promising, Celebs Fight Melanoma with L’Oreal
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-revance-rsquo-s-neurotoxin-promising-celebs-fight-melanoma-with-l-rsquo-oreal/19138/In this weeks DermwireTV, patient safety is explored, L'Oreal supports melanoma research and Revance reports positive data for novel neurotoxin.Dr. Matthias Donelan
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/scaarfx-donelan-/19250/Dr. Donelan has been treating patients with scarring following burns for more than 35 years. Although great progress has been made, he found it difficult to bring patients back to their pre-injury state. Learn about his experience with the Lumenis UltraPulse and how it has impacted patients' qualitySpot Rosacea Mimickers that Can Complicate Diagnosis and Treatment
https://practicaldermatology.com/topics/general-topics/spot-rosacea-mimickers-that-can-complicate-diagnosis-and-treatment/21705/Dermatologists are generally adept at diagnosing the various “red face” conditions, but sometimes mimickers are mistaken for rosaceaSuccessful Management of Rosacea with Lasers
https://practicaldermatology.com/topics/general-topics/successful-management-of-rosacea-with-lasers/22037/Specialists share insights to help dermatologists and patients get the most from laser therapy for rosacea.